Nachrichten zur ProQR Therapeutics N.V. Aktie

ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement

LEIDEN, the Netherlands and CAMBRIDGE, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”),…

ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement

LEIDEN, Netherlands and CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a…

ProQR Therapeutics N.V. (PRQR) ASGCT Investor Webcast (Transcript)

…

ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a…

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a…

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 19, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR),…

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a…

ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing

LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a…

ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference

LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a…

ProQR gains on deal to divest eye disease therapies

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit

LEIDEN, Netherlands & CAMBRIDGE, Mass., July 06, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a…

ProQR (PRQR) Reports Q1 Loss, Lags Revenue Estimates

ProQR (PRQR) delivered earnings and revenue surprises of 0% and 75.51%, respectively, for the quarter ended March 2023. Do the…

ProQR GAAP EPS of -€0.11, revenue of €0.66M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 6-K ProQR Therapeutics N.V. For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV.…

Will ProQR (PRQR) Report Negative Q1 Earnings? What You Should Know

ProQR (PRQR) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

ProQR Announces Upcoming Investor Conferences in April and May

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a…

ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a…

Why Shares of ProQR Therapeutics Dropped on Wednesday

The clinical-stage biotech released fourth-quarter and full-year earnings....…

Kodiak, Arcturus top healthcare gainers; ProQR, Sharecare among losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event

LEIDEN, Netherlands & CAMBRIDGE, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR),…

Form 6-K ProQR Therapeutics N.V. For: Mar 29

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing

LEIDEN, Netherlands & CAMBRIDGE, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a…

ProQR to Present at Upcoming Scientific and Industry Conferences

LEIDEN, Netherlands & CAMBRIDGE, Mass., March 07, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a…

CytomX +70% nach Moderna-Deal: Weitere Millionengewinne im NBC!

Gerade erst feierten NBC-Mitglieder einen Kursanstieg von sagenhaften +613% mit der Aktie von ProQR (WKN: A12B97) in weniger als acht…

ProQR (PRQR) Rises on Expanding RNA-Editing Deal With Eli Lilly

ProQR (PRQR) expands its existing licensing and collaboration agreement with Eli Lilly for the discovery, development and commercialization of new…

Form 6-K ProQR Therapeutics N.V. For: Dec 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ProQR: NBC-Mitglieder feiern +313% zum Weihnachtsfest!

Pünktlich zu Weihnachten bringt ProQR (WKN: A12B97), aktuelle Rakete im No Brainer Club, satte Prozente ins Depot. Die bestehende Kooperation…

ProQR adds 75% as Cantor upgrades on expanded deal with Eli Lilly

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ProQR, Oric top healthcare gainers; Rocket, Cassava among losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ProQR Therapeutics Shares Soar As Eli Lilly Expands RNA Collaboration

read more...…

Thinking about buying stock in Thermogenesis Holdings, ProQR Therapeutics, Grom Social, ORIC Pharmaceuticals, or Acasti Pharma?

NEW YORK, Dec. 22, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for THMO, PRQR, GROM, ORIC, and ACST. To…

Eli Lilly sends ProQR 35% higher after expanding RNA editing deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Lilly, ProQR To Expand Licensing And Collaboration Deal For New Genetic Medicines

INDIANAPOLIS (dpa-AFX) - Drug maker Eli Lilly and Co. (LLY) announced Thursday that it is expanding its licensing and collaboration…

ProQR Therapeutics Rises on Expanded Lilly Partnership

ProQR Therapeutics Rises on Expanded Lilly Partnership...…

Lilly and ProQR to Expand RNA Editing Collaboration

New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQRs Axiomer technology INDIANAPOLIS…

ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a…

Lilly and ProQR to Expand RNA Editing Collaboration

New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQRs Axiomer technology New…

Thinking about buying stock in Crown Electrokinetics, ThredUp, Icosavax, Engine Gaming and Media, or ProQR Therapeutics?

NEW YORK, Dec. 15, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CRKN, TDUP, ICVX, GAME, and PRQR. To…

ProQR: NBC-Favorit ballert +206% in 7 Monaten

Knaller-Storys am laufenden Band: ProQR (WKN: A12B97) macht Mitgliedern des No Brainer Club nun schon zum zweiten Mal mächtig Spaß.…

ProQR (PRQR) Reports Q3 Loss, Lags Revenue Estimates

ProQR (PRQR) delivered earnings and revenue surprises of -47.83% and 7.75%, respectively, for the quarter ended September 2022. Do the…

Form 6-K ProQR Therapeutics N.V. For: Sep 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ProQR Announces Third Quarter 2022 Operating and Financial Results

 LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the…